Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.

Carver, Alicia B; Zuckerman, Autumn D; DeClercq, Joshua; Choi, Leena; Chastain, Cody A

Carver, Alicia B; Zuckerman, Autumn D; DeClercq, Joshua; Choi, Leena; Chastain, Cody A.

Afiliação

Carver AB; Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Zuckerman AD; Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
DeClercq J; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Choi L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Chastain CA; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Open Forum Infect Dis ; 7(12): ofaa569, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33409333

Palavras-chave

antiviral agents; hepatitis C virus; rapid virologic response; sustained virologic response; viral load

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google